Alexion Pharmaceuticals | 168,0700 / +0,92% |
Datum/Vrijeme | 21.04. / 18:29 |
Promj. / Promj.(%) | 1,5300 / +0,92% |
Potražnja | 168,0500 / 400 |
Ponuda | 168,0800 / 100 |
Otvaranje | 167,7200 |
Prethodno zatvaranje | 166,5400 |
Najviša cijena | 168,5150 |
Najniža | 167,3900 |
Volumen [USD] | 101.005.987,6729 |
Volumen [Jedinice] | 900.870 |
Zaključenja cijena | 3804 |
ISIN | US0153511094 |
Simbol | ALXN |
Burza | NASDAQ |
Vrsta | Stock |
Druge burze
Burza | Posljednji | Volumen | |
---|---|---|---|
NASDAQ | 168,0700 | ![]() |
900.870 |
IEX | 168,05 | ![]() |
43.598 |
Cboe US | 168,08 | ![]() |
38.731 |
Xetra | 139,92 | ![]() |
263 |
Stuttgart | 139,620 | ![]() |
200 |
TradeGate | 139,560 | ![]() |
122 |
München | 140,02 | ![]() |
95 |
gettex | 139,880 | ![]() |
3 |
Düsseldorf | 139,44 | ![]() |
0 |
Frankfurt | 137,9800 | ![]() |
0 |
Berlin | 137,44 | ![]() |
0 |
Vienna Globa.. | 139,86 | ![]() |
0 |
Lang & Schwa.. | 139,58 | ![]() |
|
London Inter.. | 165,76 | 11 | |
Mexico | 3.140,98 | ![]() |
282 |
Vijesti
- Boehringer Ingelheim and Zealand Pharma Advance to Phase 2 Clinical Testing in NASH and Obesity
13.04.2021 / 14:00 - GlobeNewswire - Avenue Therapeutics Announces that the FDA is Still Reviewing Its NDA Resubmission for IV Tramadol
13.04.2021 / 12:30 - GlobeNewswire - Transactions in Zealand Pharma shares and/or related securities by persons discharging managerial responsibilities and/or their closely associated persons
09.04.2021 / 15:05 - GlobeNewswire - Zealand Pharma increases its share capital as a consequence of exercise of employee warrants
09.04.2021 / 14:00 - GlobeNewswire - Royalty Pharma Acquires OXLUMO™ Royalty Interest From Dicerna for up to $240 Million
08.04.2021 / 13:40 - GlobeNewswire